Jazz Pharmaceuticals JAZZ Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's common stock?
- Jazz Pharmaceuticals (JAZZ) reported common stock of $0 in Q1 2026.
- How has Jazz Pharmaceuticals's common stock changed year-over-year?
- Jazz Pharmaceuticals's common stock decreased by 100.0% year-over-year, from $6K to $0.
- What is the long-term trend for Jazz Pharmaceuticals's common stock?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's common stock has grown at a -100.0% compound annual growth rate (CAGR), from $6K to $0.
- What does common stock mean?
- The total par value of all common shares issued by the company.
- How do you interpret common stock?
- Changes are generally minimal unless there is a significant issuance of new shares or a change in par value structure.
- How does common stock compare across companies?
- Standard across all public companies; usually a very small portion of total equity.